C-X-C motif chemokine ligand 12 (CXCL12) and its receptor C-X-C motif chemokine receptor 4 (CXCR4) have emerged as promising therapeutic approaches targeting tumor growth and metastasis (5). This evidence concerns the gene CXCL12 and neoplasm.